Identification and validation of a lenvatinib resistance-related prognostic signature in HCC, in which PFKFB4 contributes to tumor progression and lenvatinib resistance
Authors
Guangjie Han (ORCID: https://orcid.org/0000-0003-2256-9356)
Man Zhao (ORCID: https://orcid.org/0000-0001-7368-1079)
Jiaojiao Hou
Ning Li
Jinfeng Wang (ORCID: https://orcid.org/0000-0001-6074-9118)
Identification and validation of a lenvatinib resistance-related prognostic signature in HCC, in which PFKFB4 contributes to tumor progression and lenvatinib resistance
Guangjie Han, Man Zhao, Jiaojiao Hou, Ning Li et al.
Citations
3 citations
Journal
BMC Gastroenterology
Topics
Hepatocellular Carcinoma Treatment and Prognosis
Field-Weighted Citation Impact (FWCI)
3.97
article
Identification and validation of a lenvatinib resistance-related prognostic signature in HCC, in which PFKFB4 contributes to tumor progression and lenvatinib resistance
Guangjie Han, Man Zhao, Jiaojiao Hou, Ning Li, Jinfeng Wang, Fei Yin, Xiaoling Duan, Xin Han, Jianfei Shi, Lili Mi
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
BMC GastroenterologyVol. 25(1)
Institutions
Hebei Medical University (CN), Fourth Hospital of Hebei Medical University (CN)